Related Experiment Video
Updated: Jul 7, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Systemic sclerosis (scleroderma)
F E Roufosse1, L M de Bellefon
1Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium. froufoss@ulb.ac.be
Abstract:
Systemic sclerosis is a rare and often debilitating disorder characterized by a pathological triad: increased deposition of extracellular matrix and collagen in tissues, microvascular damage and dysfunction, and immune activation as evidenced by inflammation and frequent occurrence of autoantibodies. Until recently, therapeutic interventions were disappointing, given their inability to alter the natural course of this disease. The recognition that early detection and treatment of visceral complications are essential for stabilising, or in some cases, reversing their progression, has contributed greatly to improving the prognosis of systemic sclerosis. Furthermore, an increased interest in understanding the pathogenic mechanisms of this complex disease has opened new perspectives for therapy, targeting the diverse and inter-related components of the characteristic triad.
Insights
Systemic sclerosis, a rare autoimmune disease, involves tissue fibrosis, vascular issues, and immune dysfunction. Early detection and targeted therapies are improving patient outcomes.
Area of Science:
- Rheumatology and Immunology
- Vascular Biology
- Pathology
Background:
- Systemic sclerosis is a rare, debilitating autoimmune disease.
- Characterized by fibrosis, vascular damage, and immune activation.
- Previous treatments had limited success in altering disease course.
Purpose of the Study:
- To highlight the importance of early detection and treatment of visceral complications.
- To explore new therapeutic perspectives targeting the disease's core mechanisms.
- To improve the prognosis of systemic sclerosis.
Main Methods:
- Review of current understanding of systemic sclerosis pathogenesis.
- Analysis of the impact of early intervention on disease progression.
- Identification of therapeutic targets within the disease triad.
Main Results:
- Early detection and management of visceral complications significantly improve prognosis.
- Understanding pathogenic mechanisms opens new therapeutic avenues.
- Targeting fibrosis, vascular dysfunction, and immune activation shows promise.
Conclusions:
- A shift towards early intervention and targeted therapies is crucial for managing systemic sclerosis.
- New therapeutic strategies focusing on the disease's multifaceted nature offer hope for better patient outcomes.
- Further research into pathogenic mechanisms will drive advancements in systemic sclerosis treatment.
Related Concept Videos
Multiple Sclerosis l: Introduction
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
